Kulkarni Sujay, Sharma Mithun, Rao Padaki N, Gupta Rajesh, Reddy Duvvuru N
Department of Gastroenterology and Hepatology, Asian Institute of Gastroenterology, Hyderabad, India.
J Clin Exp Hepatol. 2018 Jun;8(2):144-155. doi: 10.1016/j.jceh.2017.11.008. Epub 2017 Nov 23.
We studied in-hospital predictors of mortality of acute on chronic liver failure (ACLF) in Indian patients.
Patients admitted to the intensive care unit of our institute fulfilling the definition of ACLF based on the Asia-Pacific Association for Study of Liver Disease (APASL) consensus were included. Complete history and medical evaluation to assess the etiology of underlying liver cirrhosis and to identify the acute precipitating insult of worsening liver function was done. Data was prospectively recorded and various scoring systems and individual clinical and laboratory parameters were assessed to identify predictors of 28 days mortality.
64 out of 240 patients screened for ACLF were analyszed in the study. Median age was 44 years and 53% were males. Alcohol was the primary cause of cirrhosis in 60.93%. Infections and active alcoholism was the main precipitating acute insult in 43% and 37% patients respectively. 28% patients had history of ingestion of hepato-toxic drugs as the acute insult. More than one acute insult was seen in 37.5% patients and type-II hepatic injury was the most common type. 28 days in hospital mortality was 43.75% and was highest in patients with sepsis (67.8%). Presence of hepato-renal syndrome and need for ventilation was associated with poor outcome. Though multiple variables were significant in predicting mortality on univariate analysis, yet on regression model only APACHE II and shock could significantly predict mortality with odds ratio of 3.18 and 9.14 respectively. Highest mortality was seen with cerebral and lung as organ failure and mortality increased as the number of organ failure worsened. CLIF-SOFA and APACHE-II scores having area under curve > 0.8 had higher ability to predict mortality.
ACLF carries high short-term mortality and early intervention by liver transplantation should be considered in patients who shows high risk of mortality.
我们研究了印度急性慢性肝衰竭(ACLF)患者院内死亡的预测因素。
纳入我院重症监护病房收治的符合亚太肝病研究协会(APASL)共识定义的ACLF患者。进行完整的病史和医学评估,以评估潜在肝硬化的病因,并确定肝功能恶化的急性诱发因素。前瞻性记录数据,并评估各种评分系统以及个体临床和实验室参数,以确定28天死亡率的预测因素。
本研究分析了240例筛查ACLF患者中的64例。中位年龄为44岁,53%为男性。60.93%的患者中,酒精是肝硬化的主要病因。感染和酒精性肝病活动分别是43%和37%患者的主要急性诱发因素。28%的患者有摄入肝毒性药物史作为急性诱发因素。37.5%的患者有不止一种急性诱发因素,II型肝损伤是最常见的类型。28天住院死亡率为43.75%,脓毒症患者死亡率最高(67.8%)。肝肾综合征的存在和需要机械通气与不良预后相关。虽然单因素分析中有多个变量在预测死亡率方面具有统计学意义,但在回归模型中,只有急性生理与慢性健康状况评分系统II(APACHE II)和休克能显著预测死亡率,比值比分别为3.18和9.14。脑和肺作为器官衰竭时死亡率最高,且随着器官衰竭数量的增加死亡率升高。慢性肝衰竭序贯器官衰竭评估(CLIF-SOFA)和APACHE-II评分曲线下面积>0.8时预测死亡率的能力更高。
ACLF短期死亡率高,对于显示出高死亡风险的患者,应考虑早期进行肝移植干预。